Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Spectral MD Holdings, Ltd. 07 September 2023 The following amendment has been made to the 'Rosecliff Stockholders Approve Business Combination with Spectral MD at Special Meeting'...
Spectral MD Holdings, Ltd. 07 September 2023 Spectral MD Holdings, Ltd. ("Spectral MD" or the "Company") Rosecliff Stockholders Approve Business Combination with Spectral MD...
FTSE Russell on Friday announced a number of deletion changes in the FTSE UK Index series. Yourgene Health PLC will ...
Spectral MD Holdings, Ltd. 31 August 2023 Spectral MD Holdings, Ltd ("Spectral MD" or the "Company") Spectral MD Moves One Step Closer to Completion of Business Combination...
Spectral MD Holdings, Ltd. 25 August 2023 Spectral MD Holdings, Ltd ("Spectral MD" or the "Company") Exercise of Options LONDON, U.K. AND DALLAS, TX, U.S. -Spectral MD...
Spectral MD Holdings, Ltd. 17 August 2023 Spectral MD Holdings, Ltd ("Spectral MD" or the "Company") Posting of Circular and Notice of General Meeting Form S-4 approved by the...
Spectral MD Holdings, Ltd. 14 August 2023 Spectral MD Holdings, Ltd ("Spectral MD" or the "Company") Definitive Proxy Statement and Prospectus Mailed by Rosecliff Acquisition...
Spectral MD Holdings Ltd on Monday said it has received ISO 13485 certification for the manufacture and distribution ...
Spectral MD Holdings, Ltd. 14 August 2023 Spectral MD Holdings, Ltd ("Spectral MD" or the "Company") ISO 13485 Certification Received for AI-Driven DeepView(R) Wound Imaging...
Spectral MD Holdings, Ltd. 11 August 2023 Spectral MD Holdings, Ltd ("Spectral MD" or the "Company") Filing of Updated Form S-4 by Rosecliff & Updated Investor...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
